Related Experiment Videos
Tachykinin receptors and receptor subtypes
1Pharmacology Department, A. Menarini Pharmaceuticals, Florence, Italy.
Archives Internationales De Pharmacodynamie Et De Therapie
|January 1, 1995
Summary
Tachykinins, like substance P, are key neuropeptides in the nervous system. New research explores their receptors and antagonists, revealing potential receptor subtypes.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Tachykinins (substance P, neurokinin A, neurokinin B) are neuropeptides in mammalian nervous systems.
- They mediate neurogenic inflammation, pain, and autonomic functions via NK1, NK2, and NK3 receptors.
- These receptors are G protein-coupled receptors with seven transmembrane segments.
Purpose of the Study:
- To investigate the molecular interactions between tachykinins and their receptors.
- To understand how tachykinin antagonists affect these interactions.
- To explore species- and intra-species heterogeneity in tachykinin receptors.
Main Methods:
- Isolation and cloning of tachykinin receptors.
- Development of potent and selective peptide and nonpeptide antagonists.
- Molecular biology studies to analyze receptor-antagonist interactions.
Main Results:
- Antagonist development has yielded insights into tachykinin receptor function.
- Species-related heterogeneity among tachykinin receptors has been identified.
- Potential intra-species heterogeneity for NK1 and NK2 receptors suggested.
Conclusions:
- Molecular studies are crucial for confirming true tachykinin receptor subtypes.
- Understanding receptor heterogeneity is key for developing targeted therapies.
- Tachykinin antagonists offer promising avenues for neurological and inflammatory condition treatments.